LPS, dsRNA and the interferon bridge to adaptive immune responses: Trif, Tram, and other TIR adaptor proteins

Journal of Endotoxin Research

Volumn 10, Issue 2, 2004, Pages 130-136

  Hoebe, Kasper ^a   Beutler, Bruce ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adaptive immune responses; Interferon; Tram; Trif

Indexed keywords

ADAPTOR PROTEIN; ALPHA INTERFERON; B7 ANTIGEN; BETA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; DOUBLE STRANDED RNA; GAMMA INTERFERON; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 1 RECEPTOR; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE; PROTEIN TRAM; PROTEIN TRIF; STAT1 PROTEIN; STAT2 PROTEIN; TAU INTERFERON; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADAPTATION; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL INFECTION; CELL INTERACTION; CELL MATURATION; CELL STIMULATION; IMMUNE RESPONSE; INTERFERON PRODUCTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; VIRUS INFECTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; HUMANS; INTERFERONS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RNA, DOUBLE-STRANDED; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

BACTERIA (MICROORGANISMS);

EID: 2342441717     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805104225004031     Document Type: Article

References (44)

1. Skidmore BJ, Chiller JM, Morrison DC, Weigle WO. Immunological properties of bacterial lipopolysaccharide (Lps) - correlation between mitogenic, adjuvant, and immunogenic activities. J Immunol 1975; 114: 770-775.
2. Skidmore BJ, Chiller JM, Weigle WO, Riblet R, Watson J. Immunological properties of bacterial lipopolysaccharide (Lps). 3. Genetic linkage between in vitro mitogenic and in vivo adjuvant properties of LPS. J Exp Med 1976; 143: 143-150.
3. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
4. Spiegelberg HL, Takabayashi K, Beck L, Raz E. DNA-based vaccines for allergic disease. Expert Rev Vaccines 2002; 1: 169-177.
5. Spiegelberg HL, Raz E. DNA vaccines. Allergy 1999; 54 (Suppl 56): 47-48.
6. Jiang ZH, Koganty RR. Synthetic vaccines: the role of adjuvants in immune targeting. Curr Med Chem 2003; 10: 1423-1439.
7. Jenkins MK, Khoruts A, Ingulli E et al. In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001; 19: 23-45.
8. Bour-Jordan H, Blueston JA. CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 2002; 22: 1-7.
9. Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20: 29-53.
10. Schwartz JC, Zhang X, Nathenson SG, Almo SC. Structural mechanisms of costimulation. Nat Immunol 2002; 3: 427-434.
11. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747-752.
12. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998; 393: 480-483.
13. Blair PJ, Riley JL, Harlan DM et al. CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J Exp Med 2000; 191: 651-660.
14. Ochs HD, Hollenbaugh D, Aruffo A. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency. Res Immunol 1994; 145: 210-215.
15. Granucci F, Zanoni I, Feau S, Ricciardi-Castagnoli P. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J 2003; 22: 2546-2551.
16. Hoebe K, Du X, Georgel P et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424: 743-748.
17. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003; 4: 161-167.
18. Yamamoto M, Sato S, Mori K et al. A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002; 169: 6668-6672.
19. Yamamoto M, Sato S, Hemmi H et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003; 301: 640-643.
20. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461-470.
21. Le Bon A, Tough DF. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 2002; 14: 432-436.
22. O'Neill LA, Fitzgerald KA, Bowie AG. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 2003; 24: 286-290.
23. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T. TICACM-2: a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 2003; 278(50): 49751-49762.
24. Hoebe K, Janssen E, Kim SO et al. LPS- and dsRNA-induced upregulation of costimulatory molecules occurs via Trif-dependent and Trif-independent pathways. Nat Immunol 2003; 4: 1223-1229.
25. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-738.
26. Yamamoto M, Sato S, Hemmi H et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003; 4: 1144-1150.
27. Honda K, Sakaguchi S, Nakajima C et al. Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci USA 2003; 100: 10872-10877.
28. Diebold SS, Montoya M, Unger H et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003; 424: 324-328.
29. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147(927): 258-267.
30. Nagano Y, Kojima Y. Inhibition de l'infection vaccinale par le virus homologue. C R Séances Soc Biol Fil 1958; 152: 1672-1630.
31. Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14: 778-809.
32. Sen GC. Viruses and interferons. Annu Rev Microbiol 2001; 55: 255-281.
33. Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194: 863-869.
34. Toshchakov V, Jones BW, Peters PY et al. TLR4, but not TLR2, mediates IFN beta induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol 2002; 3: 392-398.
35. Hemmi H, Kaisho T, Takeda, K, Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 2003; 170: 3059-3064.
36. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255.
37. + T cells stimulated by virus-induced type I interferon. Nat Immunol 2003; 4: 1009-1015.
38. Morelli AE, Larregina AT, Ganster RW et al. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol 2000; 74: 9617-9628.
39. Yoshimura S, Bondeson J, Foxwell BM, Brennan FM, Feldmann M. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int Immunol 2001; 13: 675-683.
40. Lau JF, Horvath CM. Mechanisms of type I interferon cell signaling and STAT-mediated transcriptional responses. Mt Sinai J Med 2002; 69: 156-168.
41. Taniguchi T, Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002; 14: 111-116.
42. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623-655.
43. Zhao Z, Qian Y, Wald D, Xia YF, Geng JG, Li X. IFN regulatory factor-1 is required for the up-regulation of the CD40-NF-kappa B activator 1 axis during airway inflammation. J Immunol 2003; 170: 5674-5680.
44. Karaghiosoff M, Steinborn R, Kovarik P et al. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 2003; 4: 471-477.